Novartis' dividend yield currently stands at 3.58%, which is significantly higher than that of the healthcare sector. Read ...
Switzerland-based pesticides maker Syngenta said on Wednesday that it has acquired a repository of natural compounds and ...
Patient advocacy group Patients for Affordable Drugs (P4AD) yesterday filed its fourth amicus brief defending the Biden ...
The U.S. Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate ...
Syngenta, which has a major operational base in Greensboro, said Wednesday it has signed an agreement to acquire certain product rights from Novartis, along with the recent opening of its ...
Prior to this announcement, Novartis' dividend was comfortably covered by both cash flow and earnings. This indicates that ...
Emasan AG is offering around 26.5M shares in Swiss Novartis (NVS) through Goldman Sachs, potentially raising $3B, Pablo Mayo Cerqueiro of ...
Novartis exceeds Q4 2024 expectations with 16% sales growth, strong EPS trajectory, and strategic R&D investments. Read why ...
The "Seizures Pipeline Insight Analysis Report" drug pipelines has been added to ResearchAndMarkets.com's offering.The Seizures treatment pipeline analysis provides an overview of recent advancements ...